CTOs on the Move

Norwegian American Hospital

www.nahospital.org

 
Norwegian American Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Chicago, IL. To find more information about Norwegian American Hospital, please visit www.nahospital.org
  • Number of Employees: 25-100
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

HandsFree Health

WellBe® is a digital health platform that provides voice-activated assistance with health questions, reminders, and entertainment using a smart speaker.

Physician Health Choice

Physician Health Choice is a Corpus Christi, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alzyn

ALZYN is a development stage company pursuing a unique approach to retard the progress of Alzheimer`s Disease. The science originated at the Florida State University`s College of Medicine.

American Orthodontics

American Orthodontics is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. American Orthodontics is based in Sheboygan, WI. You can find more information on American Orthodontics at www.americanortho.com

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.